CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: prednisone
Accession: CHEBI:8382
browse the term
Definition: A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Synonyms: related_synonym: 1,2-Dehydrocortisone; 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione; 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione; Dehydrocortisone; Formula=C21H26O5; InChI=1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1; InChIKey=XOFYZVNMUHMLCC-ZPOLXVRWSA-N; SMILES=[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])C(=O)C[C@@]1(C)[C@@]2([H])CC[C@]1(O)C(=O)CO; prednison; prednisona; prednisonum
xref: Beilstein:2065301; CAS:53-03-2; DrugBank:DB00635; Drug_Central:2253; KEGG:C07370
xref_mesh: MESH:D011241
xref: PMID:10438974; PMID:15859934; PMID:18971570; PMID:23093541; PMID:23395281; Patent:US2579479; Patent:US2837464; Patent:US2897216; Patent:US3134718; Reaxys:2065301; Wikipedia:Prednisone
G
A2m
alpha-2-macroglobulin
decreases expression
ISO
Prednisone results in decreased expression of A2M protein
CTD
PMID:11304663
NCBI chr 4:154,897,770...154,947,787
Ensembl chr 4:154,897,877...154,947,786
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions increases secretion affects response to substance
ISO
Elacridar inhibits the reaction [ABCB1 protein results in increased secretion of Prednisone]; valspodar inhibits the reaction [ABCB1 protein results in increased secretion of Prednisone] ABCB1A protein affects the susceptibility to Prednisone
CTD
PMID:15502009 PMID:22464980
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcb1b
ATP-binding cassette, subfamily B (MDR/TAP), member 1B
affects response to substance
ISO
ABCB1B protein affects the susceptibility to Prednisone
CTD
PMID:15502009
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions increases activity
ISO
Prednisone promotes the reaction [ABCC3 protein affects the transport of calcein AM] Prednisone results in increased activity of ABCC3 protein
CTD
PMID:15979871
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
[Prednisone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein
CTD
PMID:29782964
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
G
Ar
androgen receptor
multiple interactions
ISO
Prednisone binds to and results in increased activity of AR protein mutant form
CTD
PMID:11956172
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Ccl11
C-C motif chemokine ligand 11
decreases expression
ISO
Prednisone results in decreased expression of CCL11 protein
CTD
PMID:15523430
NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
G
Ccl12
C-C motif chemokine ligand 12
decreases expression
ISO
Prednisone results in decreased expression of CCL13 protein
CTD
PMID:15523430
NCBI chr10:67,070,230...67,071,780
Ensembl chr10:67,070,230...67,071,780
G
Cd2ap
CD2-associated protein
multiple interactions
EXP
Prednisone affects the reaction [Doxorubicin results in increased expression of CD2AP mRNA]; Prednisone inhibits the reaction [Doxorubicin results in increased expression of CD2AP protein]
CTD
PMID:16636307
NCBI chr 9:18,086,744...18,182,744
Ensembl chr 9:18,086,984...18,182,199
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression
ISO
Prednisone results in increased expression of CDKN1A protein
CTD
PMID:15034294
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
ISO
Prednisone results in increased expression of CDKN1B protein
CTD
PMID:15034294
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn2a
cyclin-dependent kinase inhibitor 2A
increases expression
ISO
Prednisone results in increased expression of CDKN2A protein
CTD
PMID:15034294
NCBI chr 5:103,984,949...103,992,143
Ensembl chr 5:103,984,949...104,003,149
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
increases expression
ISO
Prednisone results in increased expression of CDKN2B protein
CTD
PMID:15034294
NCBI chr 5:104,009,839...104,019,082
Ensembl chr 5:104,010,680...104,019,050
G
Fabp4
fatty acid binding protein 4
multiple interactions
ISO
[Prednisone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein
CTD
PMID:29782964
NCBI chr 2:91,580,858...91,585,578
Ensembl chr 2:91,580,885...91,585,578
G
Gcg
glucagon
multiple interactions decreases expression
EXP
[Fatty Acids, Unsaturated co-treated with Prednisone] results in increased expression of GCG mRNA Prednisone results in decreased expression of GCG mRNA
CTD
PMID:12524409 PMID:14705828
NCBI chr 3:47,113,914...47,122,929
Ensembl chr 3:47,113,914...47,122,929
G
Gstm1
glutathione S-transferase mu 1
affects response to substance
ISO
GSTM1 gene polymorphism affects the susceptibility to Prednisone
CTD
PMID:15713801
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
G
Hif1a
hypoxia inducible factor 1 subunit alpha
increases activity
ISO
Prednisone results in increased activity of HIF1A protein
CTD
PMID:19502547
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
G
Ifng
interferon gamma
multiple interactions
ISO
[zafirlukast co-treated with Prednisone co-treated with Budesonide] inhibits the reaction [Antigens results in increased secretion of IFNG protein]
CTD
PMID:16160912
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Il12a
interleukin 12A
multiple interactions
ISO
Prednisone results in increased expression of [IL12A protein binds to IL12B protein]
CTD
PMID:19584951
NCBI chr 2:152,965,769...152,973,035
Ensembl chr 2:152,965,769...152,972,734
G
Il12b
interleukin 12B
multiple interactions
ISO
Prednisone results in increased expression of [IL12A protein binds to IL12B protein]
CTD
PMID:19584951
NCBI chr10:28,888,832...28,903,796
Ensembl chr10:28,893,008...28,902,903
G
Il13
interleukin 13
decreases expression
ISO
Prednisone results in decreased expression of IL13 protein
CTD
PMID:15523430
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il4
interleukin 4
decreases expression
ISO
Prednisone results in decreased expression of IL4 protein
CTD
PMID:19584951
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il5
interleukin 5
decreases expression
ISO
Prednisone results in decreased expression of IL5 protein
CTD
PMID:12722970 PMID:15523430
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
G
Ins2
insulin 2
multiple interactions
ISO
[Prednisone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein; [Prednisone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein
CTD
PMID:29782964
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
decreases expression
EXP
Prednisone results in decreased expression of JUN mRNA
CTD
PMID:12524409
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Nphs1
NPHS1 adhesion molecule, nephrin
multiple interactions
EXP
Prednisone inhibits the reaction [Doxorubicin results in decreased phosphorylation of NPHS1 protein]; Prednisone inhibits the reaction [Doxorubicin results in increased expression of NPHS1 protein]
CTD
PMID:16636307 PMID:19293598
NCBI chr 1:85,720,812...85,749,079
Ensembl chr 1:85,720,812...85,749,078
G
Nphs2
NPHS2 stomatin family member, podocin
multiple interactions
EXP
Prednisone inhibits the reaction [Doxorubicin results in increased expression of NPHS2 mRNA]
CTD
PMID:16636307
NCBI chr13:68,448,720...68,461,312
Ensembl chr13:68,448,926...68,461,313
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
ISO
Prednisone binds to and results in increased activity of NR3C1 protein
CTD
PMID:28973534
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Plat
plasminogen activator, tissue type
increases expression
ISO
Prednisone results in increased expression of PLAT protein
CTD
PMID:10452346
NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
G
Pomc
proopiomelanocortin
decreases expression
ISO
Prednisone results in decreased expression of POMC protein modified form
CTD
PMID:1977371
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Pygm
glycogen phosphorylase, muscle associated
decreases expression
ISO
Prednisone results in decreased expression of PYGM protein
CTD
PMID:8815173
NCBI chr 1:203,690,550...203,705,369
Ensembl chr 1:203,690,533...203,705,368
G
Rb1
RB transcriptional corepressor 1
multiple interactions
ISO
Prednisone results in decreased phosphorylation of and results in decreased activity of RB1 protein
CTD
PMID:15034294
NCBI chr15:48,371,295...48,502,473
Ensembl chr15:48,371,296...48,502,302
G
Serpinc1
serpin family C member 1
increases expression
ISO
Prednisone results in increased expression of SERPINC1 protein
CTD
PMID:11304663
NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
G
Slc22a2
solute carrier family 22 member 2
multiple interactions
ISO
Prednisone inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium]
CTD
PMID:21599003
NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
G
Tgfb1
transforming growth factor, beta 1
decreases expression
ISO
Prednisone results in decreased expression of TGFB1 protein
CTD
PMID:12722970
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
G
Tnf
tumor necrosis factor
increases expression
ISO
Prednisone results in increased expression of TNF protein
CTD
PMID:19584951
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tyms
thymidylate synthetase
affects response to substance
ISO
TYMS gene polymorphism affects the susceptibility to Prednisone
CTD
PMID:15713801
NCBI chr 9:113,313,454...113,329,551
Ensembl chr 9:113,313,452...113,329,536
G
Vdr
vitamin D receptor
increases expression affects response to substance
ISO
Prednisone results in increased expression of VDR protein VDR gene polymorphism affects the susceptibility to Prednisone
CTD
PMID:7662588 PMID:15713801
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
G
Vegfa
vascular endothelial growth factor A
multiple interactions
EXP
Prednisone affects the reaction [Doxorubicin results in decreased expression of VEGFA protein]
CTD
PMID:19293598
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all